Research reading room
Germ Cell Tumors and Shared Leukemias (MSK, J Clin Invest 2020)
Summary
Germ Cell Tumors and Shared Leukemias (MSK, J Clin Invest 2020) is a study catalogued by cBioPortal DataHub under the cancer-type code testis. EvidenceHelix groups it with blood, lymph and bone marrow studies.
Study description
Targeted and WES sequencing of germ cell tumor and shared leukemia samples.
Text as published in the source's study metadata.
Citation & PubMed
Taylor et al. J Clin Invest 2020
Linked PubMed records: PMID 32897884
Source & licence
Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.
Source metadata
- Study identifier
- gct_msk_2020
- Short name
- GCT(MSK 2020)
- Source cancer-type code
- testis
- Reference genome
- not given
- Source access groups
- DONOGHUM;ABDELWAO2;JTMED11;PUBLIC
- Original study
- View on cBioPortal
- Metadata file
- meta_study.txt at e1b75cd25b
- Database licence
- ODC Open Database License (ODbL) 1.0
Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.
Citations
Taylor et al. J Clin Invest 2020
Citation counts are not part of the source metadata and are not shown.
Related studies
-
Diffuse Large B-Cell Lymphoma (MSK, Haematologica 2024)
Targeted sequencing of 396 diffuse large B-cell lymphoma samples and their matched normals via MSK-IMPACT.
Blood, lymph and bone marrowMSK studiesSource code mbnPubMed 1 -
Histiocytosis Cobimetinib (MSK, Nature 2019)
Targeted and whole exome sequencing of 52 histiocytosis tumor/normal pairs.
Blood, lymph and bone marrowMSK studiesSource code hdcnPubMed 1 -
Lymphoma Cell Lines (MSK, Blood 2020)
Targeted sequencing of 34 lymphoma cell lines using HemePACT_v3
Blood, lymph and bone marrowMSK studiesSource code lymphPubMed 1 -
Mature T and NK Neoplasms (MSK, Blood Adv 2023)
Targeted sequencing of 132 Mature T and NK Neoplasms and their matched normals via MSK-IMPACT.
Blood, lymph and bone marrowMSK studiesSource code mtnnPubMed 1 -
Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015)
Comprehensive profiling of infant MLL-rearranged acute lymphoblastic leukemia (MLL-R ALL)
Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1 -
Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2016)
Whole-genome and/or whole-exome sequencing of ERG-altered B-ALL tumor/normal pairs.
Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1 -
Acute Myeloid Leukemia (OHSU, Cancer Cell 2022)
Whole-exome and transcriptomic sequencing of 942 acute myeloid leukemia samples (with 500 matched normals) from the Beat AML program.
Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1 -
Acute Myeloid Leukemia (OHSU, Nature 2018)
Whole-exome sequencing of 672 acute myeloid leukemia samples (with 454 matched normals) from the Beat AML program.
Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1